A detailed history of Black Rock Inc. transactions in Nektar Therapeutics stock. As of the latest transaction made, Black Rock Inc. holds 15,155,673 shares of NKTR stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,155,673
Previous 5,878,293 157.82%
Holding current value
$15.2 Million
Previous $5.47 Million 243.82%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.9 - $1.83 $8.35 Million - $17 Million
9,277,380 Added 157.82%
15,155,673 $18.8 Million
Q1 2024

May 10, 2024

SELL
$0.49 - $0.96 $110,702 - $216,887
-225,924 Reduced 3.7%
5,878,293 $5.47 Million
Q4 2023

Feb 13, 2024

SELL
$0.42 - $0.57 $663,773 - $900,834
-1,580,412 Reduced 20.57%
6,104,217 $3.42 Million
Q3 2023

Nov 13, 2023

SELL
$0.51 - $1.05 $469,043 - $965,677
-919,693 Reduced 10.69%
7,684,629 $4.61 Million
Q2 2023

Aug 11, 2023

SELL
$0.53 - $1.03 $14.3 Million - $27.8 Million
-26,954,636 Reduced 75.8%
8,604,322 $4.99 Million
Q1 2023

May 12, 2023

SELL
$0.64 - $3.15 $237,924 - $1.17 Million
-371,757 Reduced 1.03%
35,558,958 $24.9 Million
Q4 2022

Feb 13, 2023

BUY
$2.03 - $4.28 $1.79 Million - $3.77 Million
880,196 Added 2.51%
35,930,715 $81.2 Million
Q3 2022

Nov 14, 2022

BUY
$3.04 - $5.14 $10.6 Million - $17.9 Million
3,477,606 Added 11.01%
35,050,519 $112 Million
Q2 2022

Aug 12, 2022

BUY
$3.17 - $6.17 $17.3 Million - $33.7 Million
5,458,398 Added 20.9%
31,572,913 $120 Million
Q1 2022

May 12, 2022

SELL
$4.16 - $13.72 $2.32 Million - $7.65 Million
-557,288 Reduced 2.09%
26,114,515 $141 Million
Q4 2021

Feb 10, 2022

BUY
$10.83 - $18.41 $84.8 Million - $144 Million
7,827,559 Added 41.54%
26,671,803 $360 Million
Q3 2021

Nov 09, 2021

BUY
$13.07 - $18.84 $3.24 Million - $4.67 Million
247,972 Added 1.33%
18,844,244 $338 Million
Q2 2021

Aug 11, 2021

BUY
$16.52 - $20.4 $307 Million - $379 Million
18,596,272 New
18,596,272 $319 Million

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $187M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.